首页> 外文期刊>Bali Medical Journal >Osteogenic Potential Differentiation of Human Amnion Mesenchymal Stem Cell with Chitosan-Carbonate Apatite Scaffold (In Vitro Study)
【24h】

Osteogenic Potential Differentiation of Human Amnion Mesenchymal Stem Cell with Chitosan-Carbonate Apatite Scaffold (In Vitro Study)

机译:壳聚糖-碳酸盐磷灰石支架对人羊膜间充质干细胞的成骨潜能分化作用(体外研究)

获取原文
           

摘要

Background: Tissue engineering based approaches have received much attention. Incorporation of chitosan and carbonate apatite (CA) improve its capability. Human mesenchymal stem cells (hMSCs) is viable for xenogenic transplantation. The purpose of this study was to fabricate and evaluate the osteogenic potential diferentiation of human amnion mesenchymal stem cell with carbonate apatite–chitosan scaffolds (CA-ChSs) for tissue engineering. Method: Human amniotic membrane was procured from using cesarean section. Soncini’s protocol was employed for the isolation procedure. The cells cultured on collagen-coated dishes using Dulbecco's minimal essential medium (DMEM)/F12 (1:1). A chitosan powder of medium molecular weight deacetylated chitin, poly(D(glucosamine) was used and mixed with CA. Immunocytochemistry and flowcytometry used for phenotypic characterization of hAMSC. Result: Amniotic membrane obtained using cesarean section under aseptic condition did not exhibit any growth of cell cultures which were not contaminated. Immunocytochemistry testing revealed that the target cells expressed strong mesenchymal stem cell marker CD 105. Characterization at passage 10 showed that CD44 was the most significant and abundant surface receptors. The number of viable cells in chitosan-carbonate apatite was 66.59%. Scanning electron microscope (SEM) observation revealed that CA-ChSs had three-dimensional structure with many pores and hAMSc could attached and proliferation among the porosity of the scaffold. The formation of calcium in the cell as an indicator of osteoblast cells was detected using Alizarin Red solution. Conclusion: hAMSc harvested from human amniotic membrane seeding in CA-ChSs had the capability for in vitro osteogenesis makes them be the one of the potential options for bone tissue engineering.
机译:背景:基于组织工程学的方法已受到广泛关注。壳聚糖和碳酸盐磷灰石(CA)的结合提高了其能力。人间充质干细胞(hMSCs)可用于异种移植。这项研究的目的是制造和评估碳酸盐磷灰石-壳聚糖支架(CA-ChSs)用于组织工程的人羊膜间充质干细胞的成骨潜能分化。方法:采用剖宫产术获得人羊膜。隔离程序采用了Soncini的协议。使用Dulbecco的基本必需培养基(DMEM)/ F12(1:1)在胶原蛋白包被的培养皿上培养细胞。结果:在无菌条件下经剖宫产术得到的羊膜未见任何生长现象,使用中等分子量的脱乙酰壳多糖,聚(D(葡萄糖胺))的壳聚糖粉末并与CA混合。免疫细胞化学测试显示,靶细胞表达强力的间充质干细胞标记物CD 105,在第10代的特征显示CD44是最重要和最丰富的表面受体。 66.59%。扫描电镜观察表明,CA-ChSs具有三维结构,具有许多孔,hAMSc可以附着并在支架的孔隙中增殖,钙在细胞中的形成是成骨细胞的指示。结论:从人羊膜中提取的hAMSc CA-ChSs中的膜播种具有体外成骨的能力,使其成为骨组织工程的潜在选择之一。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号